Randomized Trial of Tirilazad Mesylate in Acute Stroke "RANTTAS"

Completed

Phase 3 Results

Summary of Purpose

To test whether early treatment with tirilazad would improve functional outcome after acute human stroke.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 August 2008.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics

Interventions

Sponsors

  • Upjohn and National Institute of Neurological Disorders and Stroke, NIH

Trial Design

Randomized, double-blinded, vehicle-controlled trial of 556 patients at 27 centers.

Contacts

  • E. Clarke Haley, Jr, MD, Department of Neurology, Box 394, University of Virginia Health Sciences Center, Charlottesville, VA 22908.

    ech@virginia.edu